Evidence for Using Doxazosin in the Treatment of Posttraumatic Stress Disorder.
There is evidence that doxazosin is effective in the treatment of posttraumatic stress disorder (PTSD). Doxazosin is a "me-too" drug of prazosin. Doxazosin has an improved absorption profile and this likely minimizes the risk for unintended adverse hypotensive effects. The availability of doxazosin in the gastrointestinal therapeutic system (GITS) form permits a higher initial daily dose (4 mg/day) while avoiding significant first-dose side effects. The treatment of PTSD with prazosin has several disadvantages due to its short duration of action (6-8 hours), which results in multiple doses being required. Prazosin may wear off and this may lead to nightmares in the latter half of the sleep. Doxazosin has significant advantages over prazosin in clinical practice because it has a long half-life and requires only once-daily dosing. This may lead to better adherence and greater effectiveness in the treatment of PTSD.
Graduate, Xavier University School of Medicine.
Cherish
C
Smith
Associate Professor, Department of Psychiatry and Behavioral Sciences, George Washington University School of Medicine and Health Sciences; and an Attending Psychiatrist, Clinical Research Program, Sheppard Pratt Health System.
Maju Mathew
MM
Koola
J Clin Psychopharmacol. 2010 Feb;30(1):84-5
20075659
Br J Clin Pharmacol. 1999 Nov;48(5):678-87
10594469
Pharmacopsychiatry. 2017 Jan;50(1):26-31
27276365
J Clin Psychiatry. 2016 May;77(5):e561-5
27249080
J Clin Endocrinol Metab. 2010 Feb;95(2):678-85
19965926
Prim Care Companion CNS Disord. 2014 Aug 21;16(4):null
25664208
Ther Adv Psychopharmacol. 2014 Feb;4(1):43-7
24490030
Prim Care Companion CNS Disord. 2014 Dec 04;16(6):null
25834757
Prim Care Companion CNS Disord. 2012;14(5):null
23469321